Vorinostat Completed Phase 1 Trials for Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) / Recurrent Adult Acute Lymphoblastic Leukemia / Adult Acute Promyelocytic Leukemia (M3) / Blastic Phase Chronic Myelogenous Leukemia / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Relapsing Chronic Myelogenous Leukemia / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Secondary Myelodysplastic Syndromes / Previously Treated Myelodysplastic Syndromes / Recurrent Adult Acute Myeloid Leukemia / Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Treatment